MEI Pharma   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2000)

Organization Overview

First Clinical Trial
2001
NCT00022295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

MEI Pharma, Inc.